Fujirebio Diagnostics’ blood test for Alzheimer’s disease offers a less expensive and less invasive alternative compared to medical imaging and tests of cerebrospinal fluid. But competition looms from blood-based tests in development by other diagnostics companies.
The post Alzheimer’s Disease Now Has Its First FDA-Cleared Blood Test appeared first on MedCity News.
